Sutro Biopharma (STRO) Other Operating Expenses (2025)

Sutro Biopharma has reported Other Operating Expenses for 1 years, with the latest figure at $2.8 million in Q4 2025.

• Quarterly Other Operating Expenses changed N/A year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.3 million (changed N/A YoY) and the FY2025 annual result came in at -$9.8 million, changed N/A from the prior year.
• Other Operating Expenses improved to $2.8 million in Q4 2025 per STRO's latest filing, from $2.2 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $16.8 million in Q1 2025 and troughed at $2.2 million in Q3 2025.